CHF 162.88
(3.52%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 390.46 Million CHF | -3.66% |
2022 | 405.31 Million CHF | 4.46% |
2021 | 388.02 Million CHF | 14.17% |
2020 | 339.86 Million CHF | 20.21% |
2019 | 282.72 Million CHF | 1.69% |
2018 | 278.01 Million CHF | 5.01% |
2017 | 264.75 Million CHF | 10.61% |
2016 | 239.35 Million CHF | 11.07% |
2015 | 215.5 Million CHF | 9.04% |
2014 | 197.63 Million CHF | 4.24% |
2013 | 189.59 Million CHF | -4.38% |
2012 | 198.27 Million CHF | 3.41% |
2011 | 191.72 Million CHF | 3.0% |
2010 | 186.15 Million CHF | -6.41% |
2009 | 198.91 Million CHF | -3.11% |
2008 | 205.28 Million CHF | -3.36% |
2007 | 212.41 Million CHF | 9.88% |
2006 | 193.31 Million CHF | 20.87% |
2005 | 159.93 Million CHF | 14.42% |
2004 | 139.77 Million CHF | -11.86% |
2003 | 158.58 Million CHF | -12.26% |
2002 | 180.74 Million CHF | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 160.84 Million CHF | 0.0% |
2023 Q2 | 204.6 Million CHF | 0.0% |
2023 FY | 390.46 Million CHF | -3.66% |
2023 Q4 | 185.86 Million CHF | 0.0% |
2022 FY | 405.31 Million CHF | 4.46% |
2022 Q2 | 232.85 Million CHF | 0.0% |
2022 Q4 | 205.21 Million CHF | 0.0% |
2021 Q2 | 224.49 Million CHF | 0.0% |
2021 Q4 | 184.07 Million CHF | 0.0% |
2021 FY | 388.02 Million CHF | 14.17% |
2020 Q4 | 208.81 Million CHF | 0.0% |
2020 FY | 339.86 Million CHF | 20.21% |
2020 Q2 | 146.1 Million CHF | 0.0% |
2019 Q2 | 140.97 Million CHF | 0.0% |
2019 FY | 282.72 Million CHF | 1.69% |
2019 Q4 | 156.29 Million CHF | 0.0% |
2018 Q2 | 128.52 Million CHF | 0.0% |
2018 Q4 | 149.49 Million CHF | 0.0% |
2018 FY | 278.01 Million CHF | 5.01% |
2017 Q2 | 120.23 Million CHF | 0.0% |
2017 Q4 | 144.52 Million CHF | 0.0% |
2017 FY | 264.75 Million CHF | 10.61% |
2016 Q4 | 127.05 Million CHF | 0.0% |
2016 FY | 239.35 Million CHF | 11.07% |
2016 Q2 | 112.29 Million CHF | 0.0% |
2015 Q2 | 96.98 Million CHF | 0.0% |
2015 FY | 215.5 Million CHF | 9.04% |
2015 Q4 | 118.51 Million CHF | 0.0% |
2014 FY | 197.63 Million CHF | 4.24% |
2014 Q2 | 87.33 Million CHF | 0.0% |
2014 Q4 | 110.3 Million CHF | 0.0% |
2013 Q2 | 88.63 Million CHF | 0.0% |
2013 FY | 189.59 Million CHF | -4.38% |
2013 Q4 | 100.96 Million CHF | 0.0% |
2012 Q1 | 49.56 Million CHF | 0.0% |
2012 Q4 | 47.39 Million CHF | -4.38% |
2012 Q3 | 49.56 Million CHF | 0.0% |
2012 Q2 | 49.56 Million CHF | 0.0% |
2012 FY | 198.27 Million CHF | 3.41% |
2011 Q3 | 47.93 Million CHF | 0.0% |
2011 FY | 191.72 Million CHF | 3.0% |
2011 Q1 | 47.93 Million CHF | 0.0% |
2011 Q2 | 47.93 Million CHF | 0.0% |
2011 Q4 | 49.56 Million CHF | 3.41% |
2010 Q3 | 46.53 Million CHF | 0.0% |
2010 FY | 186.15 Million CHF | -6.41% |
2010 Q1 | 46.53 Million CHF | 0.0% |
2010 Q2 | 46.53 Million CHF | 0.0% |
2010 Q4 | 47.93 Million CHF | 3.0% |
2009 Q2 | 49.72 Million CHF | 0.0% |
2009 FY | 198.91 Million CHF | -3.11% |
2009 Q1 | 49.72 Million CHF | 0.0% |
2009 Q3 | 49.72 Million CHF | 0.0% |
2009 Q4 | 46.53 Million CHF | -6.41% |
2008 FY | 205.28 Million CHF | -3.36% |
2008 Q1 | 51.32 Million CHF | 0.0% |
2008 Q2 | 51.32 Million CHF | 0.0% |
2008 Q3 | 51.32 Million CHF | 0.0% |
2008 Q4 | 49.72 Million CHF | -3.11% |
2007 Q1 | 53.1 Million CHF | 0.0% |
2007 Q4 | 51.32 Million CHF | -3.36% |
2007 Q3 | 53.1 Million CHF | 0.0% |
2007 Q2 | 53.1 Million CHF | 0.0% |
2007 FY | 212.41 Million CHF | 9.88% |
2006 Q2 | 48.32 Million CHF | 0.0% |
2006 Q3 | 48.32 Million CHF | 0.0% |
2006 FY | 193.31 Million CHF | 20.87% |
2006 Q4 | 53.1 Million CHF | 9.88% |
2006 Q1 | 48.32 Million CHF | 0.0% |
2005 Q4 | 48.32 Million CHF | 20.87% |
2005 FY | 159.93 Million CHF | 14.42% |
2005 Q1 | 39.98 Million CHF | 0.0% |
2005 Q2 | 39.98 Million CHF | 0.0% |
2005 Q3 | 39.98 Million CHF | 0.0% |
2004 FY | 139.77 Million CHF | -11.86% |
2004 Q4 | 39.98 Million CHF | 14.42% |
2004 Q1 | 34.94 Million CHF | 0.0% |
2004 Q2 | 34.94 Million CHF | 0.0% |
2004 Q3 | 34.94 Million CHF | 0.0% |
2003 Q2 | 39.64 Million CHF | 0.0% |
2003 Q4 | 34.94 Million CHF | -11.86% |
2003 Q3 | 39.64 Million CHF | 0.0% |
2003 FY | 158.58 Million CHF | -12.26% |
2003 Q1 | 39.64 Million CHF | 0.0% |
2002 Q4 | 39.64 Million CHF | -12.26% |
2002 Q2 | 45.18 Million CHF | 0.0% |
2002 Q1 | 45.18 Million CHF | 0.0% |
2002 FY | 180.74 Million CHF | 0.0% |
2002 Q3 | 45.18 Million CHF | 0.0% |
2001 Q4 | 45.18 Million CHF | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Relief Therapeutics Holding AG | -10.85 Million CHF | 3695.782% |
Santhera Pharmaceuticals Holding AG | 99.54 Million CHF | -292.255% |
Basilea Pharmaceutica AG | 130.84 Million CHF | -198.43% |
Bachem Holding AG | 176.96 Million CHF | -120.648% |
Siegfried Holding AG | 320.4 Million CHF | -21.865% |
Molecular Partners AG | -40.8 Million CHF | 1056.884% |